Laura Sepp-Lorenzino
2019
In 2019, Laura Sepp-Lorenzino earned a total compensation of $1.8M as Executive Vice President, Chief Scientific Officer at Intellia Therapeutics.
Compensation breakdown
| Bonus | $204,086 |
|---|---|
| Option Awards | $1,318,695 |
| Salary | $239,487 |
| Other | $221 |
| Total | $1,762,489 |
Sepp-Lorenzino received $1.3M in option awards, accounting for 75% of the total pay in 2019.
Sepp-Lorenzino also received $204.1K in bonus, $239.5K in salary and $221 in other compensation.
Rankings
In 2019, Laura Sepp-Lorenzino's compensation ranked 6,536th out of 13,971 executives tracked by ExecPay. In other words, Sepp-Lorenzino earned more than 53.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,536 out of 13,971 | 53rd |
Division Manufacturing | 2,477 out of 5,701 | 57th |
Major group Chemicals And Allied Products | 901 out of 2,200 | 59th |
Industry group Drugs | 765 out of 1,886 | 59th |
Industry In Vitro and In Vivo Diagnostic Substances | 17 out of 77 | 78th |
Source: SEC filing on April 24, 2020.
Sepp-Lorenzino's colleagues
We found four more compensation records of executives who worked with Laura Sepp-Lorenzino at Intellia Therapeutics in 2019.